These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Vasomotor Function Comparative Assessment at 1 and 2 Years Following Implantation of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold and the Xience V Everolimus-Eluting Metallic Stent in Porcine Coronary Arteries: Insights From In Vivo Angiography, Ex Vivo Assessment, and Gene Analysis at the Stented/Scaffolded Segments and the Proximal and Distal Edges. Gogas BD; Benham JJ; Hsu S; Sheehy A; Lefer DJ; Goodchild TT; Polhemus DJ; Bouchi YH; Hung OY; Yoo SY; Joshi U; Giddens DP; Veneziani A; Quyyumi A; Rapoza R; King SB; Samady H JACC Cardiovasc Interv; 2016 Apr; 9(7):728-41. PubMed ID: 27056313 [TBL] [Abstract][Full Text] [Related]
7. Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years. Onuma Y; Honda Y; Asano T; Shiomi H; Kozuma K; Ozaki Y; Namiki A; Yasuda S; Ueno T; Ando K; Furuya J; Hanaoka KI; Tanabe K; Okada K; Kitahara H; Ono M; Kusano H; Rapoza R; Simonton C; Popma JJ; Stone GW; Fitzgerald PJ; Serruys PW; Kimura T JACC Cardiovasc Interv; 2020 Jan; 13(1):116-127. PubMed ID: 31918929 [TBL] [Abstract][Full Text] [Related]
8. Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study. Toušek P; Kočka V; Malý M; Lisa L; Buděšínský T; Widimský P Heart Vessels; 2016 Jun; 31(6):841-5. PubMed ID: 25896128 [TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography evaluation of the absorb bioresorbable scaffold performance for overlap versus non-overlap segments in patients with coronary chronic total occlusion: insight from the GHOST-CTO registry. Pereira GTR; La Manna A; Ichibori Y; Vergara-Martel A; Ramos Nascimento B; Samdani AJ; Capodanno D; D'Agosta G; Gravina G; Venuti G; Tamburino C; F Attizzani G Int J Cardiovasc Imaging; 2019 Oct; 35(10):1767-1776. PubMed ID: 31175527 [TBL] [Abstract][Full Text] [Related]
10. Long-Term Coronary Functional Assessment of the Infarct-Related Artery Treated With Everolimus-Eluting Bioresorbable Scaffolds or Everolimus-Eluting Metallic Stents: Insights of the TROFI II Trial. Gomez-Lara J; Brugaletta S; Ortega-Paz L; Vandeloo B; Moscarella E; Salas M; Romaguera R; Roura G; Ferreiro JL; Teruel L; Gracida M; Windecker S; Serruys PW; Gomez-Hospital JA; Sabaté M; Cequier A JACC Cardiovasc Interv; 2018 Aug; 11(16):1559-1571. PubMed ID: 29805111 [TBL] [Abstract][Full Text] [Related]
11. First serial optical coherence tomography assessment at baseline, 12 and 24 months in STEMI patients treated with the second-generation Absorb bioresorbable vascular scaffold. Kochman J; Kołtowski Ł; Tomaniak M; Jąkała J; Proniewska K; Legutko J; Roleder T; Piertrasik A; Rdzanek A; Kochman W; Brugaletta S; Opolski G; Regar E EuroIntervention; 2018 Apr; 13(18):e2201-e2209. PubMed ID: 29155384 [TBL] [Abstract][Full Text] [Related]
12. Coronary Endothelium-Dependent Vasomotor Function After Drug-Eluting Stent and Bioresorbable Scaffold Implantation. Gomez-Lara J; Oyarzabal L; Ortega-Paz L; Brugaletta S; Romaguera R; Salvatella N; Roura G; Rivero F; Fuentes L; Alfonso F; Otaegui I; Vandeloo B; Vaquerizo B; Sabate M; Comin-Colet J; Gomez-Hospital JA J Am Heart Assoc; 2021 Nov; 10(22):e022123. PubMed ID: 34729992 [TBL] [Abstract][Full Text] [Related]
13. Early coverage of drug-eluting stents analysed by optical coherence tomography: evidence of the impact of stent apposition and strut characteristics on the neointimal healing process. Lee R; Foin N; Ng J; Allen J; Soh N; Ang I; Shim W; Torii R; Wong P EuroIntervention; 2016 Aug; 12(5):e605-14. PubMed ID: 27497360 [TBL] [Abstract][Full Text] [Related]
14. Bioresorbable vascular scaffolds in coronary chronic total occlusions: clinical, vasomotor and optical coherence tomography findings at three-year follow-up (ABSORB-CTO study). Gheorghe L; Millán X; Jimenez-Kockar M; Gomez-Lara J; Arzamendi D; Danduch L; Agudelo V; Serra A EuroIntervention; 2019 May; 15(1):99-107. PubMed ID: 30277460 [TBL] [Abstract][Full Text] [Related]
15. Clinical, Angiographic, Functional, and Imaging Outcomes 12 Months After Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds in Acute Coronary Syndromes. Gori T; Schulz E; Hink U; Kress M; Weiers N; Weissner M; Jabs A; Wenzel P; Capodanno D; Münzel T JACC Cardiovasc Interv; 2015 May; 8(6):770-777. PubMed ID: 25999097 [TBL] [Abstract][Full Text] [Related]
16. Serial Baseline, 12-, 24-, and 60-Month Optical Coherence Tomography Evaluation of ST Segment Elevation Myocardial Infarction Patients Treated with Absorb Bioresorbable Vascular Scaffold. Koltowski L; Tomaniak M; Ochijewicz D; Zieliński K; Proniewska K; Malinowski KP; Zaleska M; Maksym J; Roleder T; Partyka L; Kochman W; Filipiak KJ; Opolski G; Kochman J Am J Cardiol; 2021 Sep; 155():23-31. PubMed ID: 34315572 [TBL] [Abstract][Full Text] [Related]
17. Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? Brugaletta S; Heo JH; Garcia-Garcia HM; Farooq V; van Geuns RJ; de Bruyne B; Dudek D; Smits PC; Koolen J; McClean D; Dorange C; Veldhof S; Rapoza R; Onuma Y; Bruining N; Ormiston JA; Serruys PW Eur Heart J; 2012 Jun; 33(11):1325-33. PubMed ID: 22507972 [TBL] [Abstract][Full Text] [Related]
18. Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial. Sotomi Y; Onuma Y; Dijkstra J; Miyazaki Y; Kozuma K; Tanabe K; Popma JJ; de Winter RJ; Serruys PW; Kimura T Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):59-66. PubMed ID: 28158421 [TBL] [Abstract][Full Text] [Related]
19. Coronary vasomotor function and myocardial flow with bioresorbable vascular scaffolds or everolimus-eluting metallic stents: a randomised trial. Gomez-Lara J; Salvatella N; Romaguera R; Brugaletta S; Ñato M; Roura G; Ferreiro JL; Teruel L; Gracida M; Sabate M; Vaquerizo B; Cequier À; Gomez-Hospital JA; EuroIntervention; 2020 Jun; 16(2):e155-e163. PubMed ID: 31217148 [TBL] [Abstract][Full Text] [Related]
20. Re-endothelialisation after Synergy stent and Absorb bioresorbable vascular scaffold implantation in acute myocardial infarction: COVER-AMI study. Lhermusier T; Ohayon P; Boudou N; Bouisset F; Campelo-Parada F; Roncalli J; Elbaz M; Carrié D Trials; 2019 Apr; 20(1):210. PubMed ID: 30975219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]